ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 171 filers reported holding ANI PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $256,000 | +1.2% | 7,788 | +7.9% | 0.01% | 0.0% |
| Q2 2021 | $253,000 | -13.7% | 7,219 | -11.1% | 0.01% | -17.6% |
| Q1 2021 | $293,000 | +4.6% | 8,117 | -15.9% | 0.02% | -15.0% |
| Q4 2020 | $280,000 | -63.8% | 9,652 | -64.8% | 0.02% | -20.0% |
| Q3 2020 | $773,000 | -43.9% | 27,404 | -35.6% | 0.02% | -30.6% |
| Q2 2020 | $1,377,000 | +38.3% | 42,566 | +211.3% | 0.04% | +200.0% |
| Q3 2019 | $996,000 | +53.9% | 13,672 | +73.8% | 0.01% | -7.7% |
| Q2 2019 | $647,000 | +110.7% | 7,868 | +80.5% | 0.01% | +116.7% |
| Q1 2019 | $307,000 | +6.6% | 4,359 | +1.1% | 0.01% | -14.3% |
| Q2 2018 | $288,000 | -15.8% | 4,313 | -26.7% | 0.01% | -30.0% |
| Q1 2018 | $342,000 | – | 5,881 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |